Clinical Trials Directory

Trials / Unknown

UnknownNCT02916654

Sucrosomial Iron in Patients With Celiac Disease and IDA

Sucrosomial Iron Supplementation in Anaemic Patients With Celiac Disease Not Tolerating Oral Ferrous Sulfate

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Sucrosomial iron (Sideral® Forte) is a preparation of ferric pyrophosphate conveyed within a phospholipid membrane associated with ascorbic acid, is a new-generation oral iron which shows a high gastrointestinal absorption and high bioavailability with a low incidence of side effects due to lack of any direct contact with intestinal mucosa. In comparison with the other standard oral iron preparations, sucrosomial iron seems to be a promising new strategy of iron replacement in CD patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTsucrosomial ironadministration of sucrosomial iron
DRUGSulphate ironadministration of sulphate iron

Timeline

Start date
2015-04-01
Primary completion
2016-08-01
Completion
2017-12-01
First posted
2016-09-27
Last updated
2017-03-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02916654. Inclusion in this directory is not an endorsement.

Sucrosomial Iron in Patients With Celiac Disease and IDA (NCT02916654) · Clinical Trials Directory